KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Accumulated Expenses (2017 - 2025)

Cardlytics' Accumulated Expenses history spans 9 years, with the latest figure at $6.1 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses fell 14.91% year-over-year to $6.1 million; the TTM value through Dec 2025 reached $6.1 million, down 14.91%, while the annual FY2025 figure was $6.1 million, 14.91% down from the prior year.
  • Accumulated Expenses reached $6.1 million in Q4 2025 per CDLX's latest filing, down from $7.5 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $21.0 million in Q2 2022 to a low of $4.3 million in Q1 2024.
  • Average Accumulated Expenses over 5 years is $9.7 million, with a median of $8.3 million recorded in 2021.
  • Peak YoY movement for Accumulated Expenses: skyrocketed 255.76% in 2021, then crashed 50.07% in 2023.
  • A 5-year view of Accumulated Expenses shows it stood at $19.6 million in 2021, then plummeted by 46.55% to $10.5 million in 2022, then increased by 11.21% to $11.7 million in 2023, then tumbled by 38.48% to $7.2 million in 2024, then dropped by 14.91% to $6.1 million in 2025.
  • Per Business Quant, the three most recent readings for CDLX's Accumulated Expenses are $6.1 million (Q4 2025), $7.5 million (Q3 2025), and $6.5 million (Q2 2025).